Vimarsana
Biggest News Aggregation in the World

Norbert Lowe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Norbert Lowe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Norbert Lowe Today - Breaking & Trending Today

Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th - Vimarsana News

Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic pharmaceutical technology company, tod...

Eyenovia Announces FDA Approval of Redwood City as Commercial Manufacturing Facility - Vimarsana News

Eyenovia Announces FDA Approval of Redwood City as Commercial Manufacturing Facility

Redwood City, California to complement Eyenovia’s facility in Reno, Nevada as well as its contract manufacturer, Coastline International, to produce commercial supply of Mydcombi NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company, today announced that the company’s facility in Redwood City, California successfully completed FDA inspection for approval as a commercial manufacturing facility. The Redwood City facility will primarily be

Source: yahoo.com
Eyenovia to Report Third Quarter 2023 Results on Monday, November 13 - Vimarsana News

Eyenovia to Report Third Quarter 2023 Results on Monday, November 13

06.11.2023 - Company to host an investor conference call and webcast at 4:30pm EDTNEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) - Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company commercializing Mydcombi for mydriasis, preparing for regulatory ...

Eyenovia to Present at Upcoming H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference - Vimarsana News

Eyenovia to Present at Upcoming H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference

NEW YORK, Aug. 09, 2023 -- Eyenovia, Inc. , an ophthalmic technology company commercializing Mydcombi™ 1%/2.5% for mydriasis and developing the Optejet® device for use both in connection with...

Eyenovia Expands Its US Manufacturing Capabilities - Vimarsana News

Eyenovia Expands Its US Manufacturing Capabilities

Eyenovia is stepping up the capabilities of its facilities and taking advantage of the thriving innovation culture and expertise in Reno, Nevada, ...